Covidien (COV) Tops Q4 EPS by 13c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts COV Hot Sheet
Price: $106.71 --0%
Financial Fact:
Restructuring charges, net: -2M
Today's EPS Names:
ATS, SICP, FTCO, More
Financial Fact:
Restructuring charges, net: -2M
Today's EPS Names:
ATS, SICP, FTCO, More
Join SI Premium – FREE
Covidien (NYSE: COV) reported Q4 EPS of $1.15, $0.13 better than the analyst estimate of $1.02. Revenue for the quarter came in at $2.73 billion versus the consensus estimate of $2.69 billion.
For earnings history and earnings-related data on Covidien (COV) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Twilio (TWLO) PT Raised to $320 at Tigress Financial Partners
- Stifel Positive on Rapport Therapeutics (RAPP): 'remains on track to share longer-term safety data from the ph2a in 4Q26'
- Walmart stock climbs on AI shopping tool expansion
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
